|Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases|
AB Kunnumakkara, D Bordoloi, G Padmavathi, J Monisha, NK Roy, ...
British journal of pharmacology 174 (11), 1325-1348, 2017
|Curcumin mediates anticancer effects by modulating multiple cell signaling pathways|
AB Kunnumakkara, D Bordoloi, C Harsha, K Banik, SC Gupta, ...
Clinical science 131 (15), 1781-1799, 2017
|The potential role of boswellic acids in cancer prevention and treatment|
NK Roy, A Deka, D Bordoloi, S Mishra, AP Kumar, G Sethi, ...
Cancer letters 377 (1), 74-86, 2016
|Possible use of Punica granatum (Pomegranate) in cancer therapy|
AD Khwairakpam, D Bordoloi, KK Thakur, J Monisha, F Arfuso, G Sethi, ...
Pharmacological research 133, 53-64, 2018
|Is curcumin bioavailability a problem in humans: lessons from clinical trials|
AB Kunnumakkara, C Harsha, K Banik, R Vikkurthi, BL Sailo, D Bordoloi, ...
Expert opinion on drug metabolism & toxicology 15 (9), 705-733, 2019
|An update on pharmacological potential of boswellic acids against chronic diseases|
NK Roy, D Parama, K Banik, D Bordoloi, AK Devi, KK Thakur, ...
International journal of molecular sciences 20 (17), 4101, 2019
|Therapeutic potential of gambogic acid, a caged xanthone, to target cancer|
K Banik, C Harsha, D Bordoloi, BL Sailo, G Sethi, HC Leong, F Arfuso, ...
Cancer letters 416, 75-86, 2018
|Tocotrienols: The promising analogues of vitamin E for cancer therapeutics|
BL Sailo, K Banik, G Padmavathi, M Javadi, D Bordoloi, ...
Pharmacological research 130, 259-272, 2018
|Butein in health and disease: A comprehensive review|
G Padmavathi, NK Roy, D Bordoloi, F Arfuso, S Mishra, G Sethi, ...
Phytomedicine 25, 118-127, 2017
|FBXW7 in cancer: what has been unraveled thus far?|
BL Sailo, K Banik, S Girisa, D Bordoloi, L Fan, CE Halim, H Wang, ...
Cancers 11 (2), 246, 2019
|Multi-targeted agents in cancer cell chemosensitization: What we learnt from curcumin thus far|
D Bordoloi, N K Roy, J Monisha, G Padmavathi, A B Kunnumakkara
Recent patents on anti-cancer drug discovery 11 (1), 67-97, 2016
|Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets|
K Banik, AM Ranaware, V Deshpande, SP Nalawade, G Padmavathi, ...
Pharmacological research 144, 192-209, 2019
|Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression|
G Padmavathi, K Banik, J Monisha, D Bordoloi, B Shabnam, F Arfuso, ...
Cancer letters 432, 260-271, 2018
|Alarming burden of triple-negative breast cancer in India|
KK Thakur, D Bordoloi, AB Kunnumakkara
Clinical breast cancer 18 (3), e393-e399, 2018
|Googling the Guggul (Commiphora and Boswellia) for prevention of chronic diseases|
AB Kunnumakkara, K Banik, D Bordoloi, C Harsha, BL Sailo, ...
Frontiers in pharmacology 9, 686, 2018
|Potential of butein, a tetrahydroxychalcone to obliterate cancer|
G Padmavathi, SR Rathnakaram, J Monisha, D Bordoloi, NK Roy, ...
Phytomedicine 22 (13), 1163-1171, 2015
|Antiulcer properties of fruits and vegetables: A mechanism based perspective|
C Harsha, K Banik, D Bordoloi, AB Kunnumakkara
Food and Chemical Toxicology 108, 104-119, 2017
|NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance|
J Monisha, NK Roy, G Padmavathi, K Banik, D Bordoloi, AD Khwairakpam, ...
Cancers 10 (7), 228, 2018
|Specific targeting of Akt kinase isoforms: Taking the precise path for prevention and treatment of cancer|
N Kishor Roy, D Bordoloi, J Monisha, G Padmavathi, J Kotoky, R Golla, ...
Current drug targets 18 (4), 421-435, 2017
|TIPE family of proteins and its implications in different chronic diseases|
D Bordoloi, K Banik, B Shabnam, G Padmavathi, J Monisha, F Arfuso, ...
International journal of molecular sciences 19 (10), 2974, 2018